Patent details

EP2916827 Title: METHODS FOR THE TREATMENT OF OCULAR DISEASE IN HUMAN SUBJECTS

Basic Information

Publication number:
EP2916827
PCT Application Number:
US2013069156
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP138537774
PCT Publication Number:
WO2014074823
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS FOR THE TREATMENT OF OCULAR DISEASE IN HUMAN SUBJECTS
French Title of Invention:
PROCÉDÉS POUR LE TRAITEMENT DE MALADIES OCULAIRES CHEZ DES SUJETS HUMAINS
German Title of Invention:
VERFAHREN ZUR BEHANDLUNG VON AUGENKRANKHEITEN BEI MENSCHLICHEN PATIENTEN
SPC Number:

Dates

Filing date:
08/11/2013
Grant date:
10/06/2020
EP Publication Date:
16/09/2015
PCT Publication Date:
15/05/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/06/2020
EP B1 Publication Date:
10/06/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/11/2020
Expiration date:
08/11/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/10/2020
 
 

Name:
Clearside Biomedical, Inc.
Address:
900 North Point Parkway Suite 200, Alpharetta, Georgia 30005, United States (US)

History of Owners

From:
03/06/2020
To:
09/10/2020

Name:
Clearside Biomedical Inc.
Address:
1220 Old Alpharetta Road Suite 300, Alpharetta, Georgia 30005, United States (US)

Inventor

1

Name:
PATEL, Samirkumar
Address:
United States (US)

2

Name:
NORONHA, Glenn
Address:
United States (US)

3

Name:
WHITE, Daniel
Address:
United States (US)

4

Name:
BURKE, Brian
Address:
United States (US)

5

Name:
ZARNITSYN, Vladimir
Address:
United States (US)

Priority

1

Priority Number:
201261724144 P
Priority Date:
08/11/2012
Priority Country:
United States (US)

2

Priority Number:
201261734872 P
Priority Date:
07/12/2012
Priority Country:
United States (US)

3

Priority Number:
201261745237 P
Priority Date:
21/12/2012
Priority Country:
United States (US)

4

Priority Number:
201361773124 P
Priority Date:
05/03/2013
Priority Country:
United States (US)

5

Priority Number:
201361785229 P
Priority Date:
14/03/2013
Priority Country:
United States (US)

6

Priority Number:
201361819388 P
Priority Date:
03/05/2013
Priority Country:
United States (US)

7

Priority Number:
201361873660 P
Priority Date:
04/09/2013
Priority Country:
United States (US)

8

Priority Number:
201361898926 P
Priority Date:
01/11/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 9/10; A61K 9/16; A61K 9/48; A61K 31/4439; A61K 31/573; A61K 39/00; A61K 45/06; A61K 47/12; A61K 47/26; A61K 47/38; A61M 37/00; A61P 27/02; C07K 16/22;

Publication

European Patent Bulletin

1

Issue number:
202024
Publication date:
10/06/2020
Description:
Grant (B1)

2

Issue number:
202029
Publication date:
15/07/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202046
Publication date:
11/11/2020
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages